First Isolation of bla VIM-2 in Klebsiella oxytoca Clinical Isolates from Portugal
Open Access
- 1 January 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (1), 476
- https://doi.org/10.1128/aac.49.1.476.2005
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Class 1 Integron Containing Metallo-β-Lactamase Gene bla VIM-2 in Pseudomonas aeruginosa Clinical Strains Isolated in JapanAntimicrobial Agents and Chemotherapy, 2004
- VIM-1 Metallo-β-Lactamase-Producing Klebsiella pneumoniae Strains in Greek HospitalsJournal of Clinical Microbiology, 2003
- Evaluation of a New Etest for Detecting Metallo-β-Lactamases in Routine Clinical TestingJournal of Clinical Microbiology, 2002
- Emerging carbapenemases in Gram-negative aerobesClinical Microbiology & Infection, 2002
- Metallo-β-Lactamase VIM-2 in Clinical Isolates ofPseudomonas aeruginosafrom PortugalMicrobial Drug Resistance, 2002
- Carbapenem-Resistant Pseudomonas aeruginosa with Acquired blavim Metallo-ß-Lactamase Determinants, ItalyEmerging Infectious Diseases, 2000
- Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in FranceAntimicrobial Agents and Chemotherapy, 2000
- Cloning and Characterization of bla VIM , a New Integron-Borne Metallo-β-Lactamase Gene from a Pseudomonas aeruginosa Clinical IsolateAntimicrobial Agents and Chemotherapy, 1999
- PCR mapping of integrons reveals several novel combinations of resistance genesAntimicrobial Agents and Chemotherapy, 1995